22nd Century Group Investor Relations Material

22nd Century Group Inc. is a biotechnology company focused on plant-based technology aimed at improving health and reducing harm in various industries. The company specializes in the genetic engineering of plants, with a primary focus on developing low-nicotine tobacco plants and hemp/cannabis plants with optimized cannabinoid profiles. 22nd Century Group’s technology is designed to support the development of products with reduced nicotine content for the tobacco industry and enhanced cannabinoids for the hemp and cannabis sectors. The company is headquartered in Buffalo, New York, and its shares are listed on the NASDAQ.